🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors market the substance there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could result in individuals administering products of uncertain source.

Several experts said the demand for retatrutide could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and consumer laws, risking fines, prosecution or prison.

Service Response and Material Elimination

According to TikTok, the service has taken down problematic content and prohibited related hashtags and search suggestions. The company stated it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Investigations also discovered groups with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with images of slimming results, positive testimonials and detailed guides for preparing or administering at home.

After minutes of entering one community, a seller posted WhatsApp details, where most transactions take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Inside these groups, posts show black plastic parcels with Royal Mail labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with sterile water, or pre-filled pens usually sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Safety Measures

A representative for Telegram stated it actively monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they can’t verify. Even if the research behind this drug is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her staff has already seen patients harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to possibly significant health risks”.